Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Disease
1.1.1.2 Pathogen
1.1.1.3 Drug Class
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.3 Competitive Insights
Chapter 3 Antibiotic Resistance Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Treatment Cost Trend
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 High burden of antibiotic-resistant infections
3.4.1.2 Increase in global initiatives drives new drug development
3.4.2 Market restraint analysis
3.4.2.1 High cost of therapeutics
3.4.3 Industry challenges
3.5 Antibiotic Resistance Market Analysis Tools
3.5.1 Industry analysis – Porter’s
3.5.2 PESTLE Analysis
3.5.3 Market entry strategies
Chapter 4 Antibiotic Resistance Market – Segment Analysis, By Disease, 2018 – 2030 (USD Million)
4.1 Antibiotic Resistance Market: Disease Movement Analysis
4.2 CDI
4.2.1 CDI market estimates and forecast, 2018 – 2030 (USD Million)
4.3 cIAI
4.3.1 cIAI market estimates and forecast, 2018 – 2030 (USD Million)
4.4 ABSSSI
4.4.1 ABSSSI market estimates and forecast, 2018 – 2030 (USD Million)
4.5 HABP
4.5.1 HABP market estimates and forecast, 2018 – 2030 (USD Million)
4.6 CABP
4.6.1 CABP market estimates and forecast, 2018 – 2030 (USD Million)
4.7 cUTI
4.7.1 cUTI market estimates and forecast, 2018 – 2030 (USD Million)
4.8 BSI
4.8.1 BSI market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 5 Antibiotic Resistance Market – Segment Analysis, By Pathogen, 2018 – 2030 (USD Million)
5.1 Antibiotic Resistance Market: Pathogen Movement Analysis
5.2 . Baumannii
5.2.1 . Baumannii market estimates and forecast, 2018 – 2030 (USD Million)
5.3 S. Aureus
5.3.1 S. Aureus market estimates and forecast, 2018 – 2030 (USD Million)
5.4 P. Aeruginosa
5.4.1 P. Aeruginosa market estimates and forecast, 2018 – 2030 (USD Million)
5.5 E. Coli
5.5.1 E. Coli market estimates and forecast, 2018 – 2030 (USD Million)
5.6 E. Faecium
5.6.1 E. Faecium market estimates and forecast, 2018 – 2030 (USD Million)
5.7 S. Pneumoniae
5.7.1 S. Pneumoniae market estimates and forecast, 2018 – 2030 (USD Million)
5.8 H. Influenzae
5.8.1 H. Influenzae market estimates and forecast, 2018 – 2030 (USD Million)
5.9 C. Difficile
5.9.1 C. Difficile market estimates and forecast, 2018 – 2030 (USD Million)
5.10 K. Pneumoniae
5.10.1 K. Pneumoniae market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 6 Antibiotic Resistance Market – Segment Analysis, By Drug Class, 2018 – 2030 (USD Million)
6.1 Antibiotic Resistance Market: Drug Class Movement Analysis
6.2 Tetracyclines
6.2.1 Tetracyclines market estimates and forecast, 2018 – 2030 (USD Million)
6.3 Oxazolidinones
6.3.1 Oxazolidinones market estimates and forecast, 2018 – 2030 (USD Million)
6.4 Cephalosporins
6.4.1 Cephalosporins market estimates and forecast, 2018 – 2030 (USD Million)
6.5 Lipoglycopeptides
6.5.1 Lipoglycopeptides market estimates and forecast, 2018 – 2030 (USD Million)
6.6 Combination therpaies
6.6.1 Combination therpaies market estimates and forecast, 2018 – 2030 (USD Million)
6.7 Others
6.7.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7 Antibiotic Resistance Market – Segment Analysis, By Mechanism of Action, 2018 – 2030 (USD Million)
7.1 Antibiotic Resistance Market: Mechanism of Action Movement Analysis
7.2 Cell Wall Synthesis Inhibitors
7.2.1 Cell wall synthesis inhibitors market estimates and forecast, 2018 – 2030 (USD Million)
7.3 Protein Synthesis Inhibitors
7.3.1 Protein synthesis inhibitors market estimates and forecast, 2018 – 2030 (USD Million)
7.4 DNA Synthesis Inhibitors
7.4.1 DNA synthesis inhibitors market estimates and forecast, 2018 – 2030 (USD Million)
7.5 RNA synthesis inhibitors
7.5.1 RNA synthesis inhibitors market estimates and forecast, 2018 – 2030 (USD Million)
7.6 Others
7.6.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Antibiotic Resistance Market – Segment Analysis, By Distribution Channel, 2018 – 2030 (USD Million)
8.1 Antibiotic Resistance Market: Distribution Channel Movement Analysis
8.2 Hospital Pharmacies
8.2.1 Hospital Pharmacies market estimates and forecast, 2018 – 2030 (USD Million)
8.3 Retail Pharmacies
8.3.1 Retail Pharmacies market estimates and forecast, 2018 – 2030 (USD Million)
8.4 Online Pharmacies
8.4.1 Online Pharmacies market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9 Antibiotic Resistance Market – Segment Analysis, By Region, 2018 – 2030 (USD Million)
9.1 Regional Market Snapshot
9.1.1 North America
9.1.1.1 North America antibiotic resistance market estimates and forecast, 2018-2030 (USD Million)
9.1.1.2 U.S.
9.1.1.2.1 U.S. antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.1.2.2 Key country dynamics
9.1.1.2.3 Disease prevalence
9.1.1.2.4 Regulatory framework
9.1.1.2.5 Competitive scenario
9.1.1.3 Canada
9.1.1.3.1 Canada antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.1.3.2 Key country dynamics
9.1.1.3.3 Disease prevalence
9.1.1.3.4 Regulatory framework
9.1.1.3.5 Competitive scenario
9.1.2 Europe
9.1.2.1 Europe antibiotic resistance market estimates and forecast, 2018-2030 (USD Million)
9.1.2.2 UK
9.1.2.2.1 UK antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.2.2 Key country dynamics
9.1.2.2.3 Disease prevalence
9.1.2.2.4 Regulatory framework
9.1.2.2.5 Competitive scenario
9.1.2.3 Germany
9.1.2.3.1 Germany antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.3.2 Key country dynamics
9.1.2.3.3 Disease prevalence
9.1.2.3.4 Regulatory framework
9.1.2.3.5 Competitive scenario
9.1.2.4 France
9.1.2.4.1 France antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.4.2 Key country dynamics
9.1.2.4.3 Disease prevalence
9.1.2.4.4 Regulatory framework
9.1.2.4.5 Competitive scenario
9.1.2.5 Italy
9.1.2.5.1 Italy antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.5.2 Key country dynamics
9.1.2.5.3 Disease prevalence
9.1.2.5.4 Regulatory framework
9.1.2.5.5 Competitive scenario
9.1.2.6 Spain
9.1.2.6.1 Spain antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.6.2 Key country dynamics
9.1.2.6.3 Disease prevalence
9.1.2.6.4 Regulatory framework
9.1.2.6.5 Competitive scenario
9.1.2.7 Denmark
9.1.2.7.1 Denmark antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.7.2 Key country dynamics
9.1.2.7.3 Disease prevalence
9.1.2.7.4 Regulatory framework
9.1.2.7.5 Competitive scenario
9.1.2.8 Sweden
9.1.2.8.1 Sweden antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.8.2 Key country dynamics
9.1.2.8.3 Disease prevalence
9.1.2.8.4 Regulatory framework
9.1.2.8.5 Competitive scenario
9.1.2.9 Norway
9.1.2.9.1 Norway antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.2.9.2 Key country dynamics
9.1.2.9.3 Disease prevalence
9.1.2.9.4 Regulatory framework
9.1.2.9.5 Competitive scenario
9.1.3 Asia Pacific
9.1.3.1 Asia Pacific antibiotic resistance market estimates and forecast, 2018-2030 (USD Million)
9.1.3.2 Japan
9.1.3.2.1 Japan antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.3.2.2 Key country dynamics
9.1.3.2.3 Disease prevalence
9.1.3.2.4 Regulatory framework
9.1.3.2.5 Competitive scenario
9.1.3.3 China
9.1.3.3.1 China antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.3.3.2 Key country dynamics
9.1.3.3.3 Disease prevalence
9.1.3.3.4 Regulatory framework
9.1.3.3.5 Competitive scenario
9.1.3.4 India
9.1.3.4.1 India antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.3.4.2 Key country dynamics
9.1.3.4.3 Disease prevalence
9.1.3.4.4 Regulatory framework
9.1.3.4.5 Competitive scenario
9.1.3.5 South Korea
9.1.3.5.1 South Korea antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.3.5.2 Key country dynamics
9.1.3.5.3 Disease prevalence
9.1.3.5.4 Regulatory framework
9.1.3.5.5 Competitive scenario
9.1.3.6 Australia
9.1.3.6.1 Australia antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.3.6.2 Key country dynamics
9.1.3.6.3 Disease prevalence
9.1.3.6.4 Regulatory framework
9.1.3.6.5 Competitive scenario
9.1.3.7 Thailand
9.1.3.7.1 Thailand antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.3.7.2 Key country dynamics
9.1.3.7.3 Disease prevalence
9.1.3.7.4 Regulatory framework
9.1.3.7.5 Competitive scenario
9.1.4 Latin America
9.1.4.1 Latin America antibiotic resistance market estimates and forecast, 2018-2030 (USD Million)
9.1.4.2 Brazil
9.1.4.2.1 Brazil antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.4.2.2 Key country dynamics
9.1.4.2.3 Disease prevalence
9.1.4.2.4 Regulatory framework
9.1.4.2.5 Competitive scenario
9.1.4.3 Mexico
9.1.4.3.1 Mexico antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.4.3.2 Key country dynamics
9.1.4.3.3 Disease prevalence
9.1.4.3.4 Regulatory framework
9.1.4.3.5 Competitive scenario
9.1.4.4 Argentina
9.1.4.4.1 Argentina antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.4.4.2 Key country dynamics
9.1.4.4.3 Disease prevalence
9.1.4.4.4 Regulatory framework
9.1.4.4.5 Competitive scenario
9.1.5 MEA
9.1.5.1 MEA antibiotic resistance market estimates and forecast, 2018-2030 (USD Million)
9.1.5.2 South Africa
9.1.5.2.1 South Africa antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.5.2.2 Key country dynamics
9.1.5.2.3 Disease prevalence
9.1.5.2.4 Regulatory framework
9.1.5.2.5 Competitive scenario
9.1.5.3 Saudi Arabia
9.1.5.3.1 Saudi Arabia antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.5.3.2 Key country dynamics
9.1.5.3.3 Disease prevalence
9.1.5.3.4 Regulatory framework
9.1.5.3.5 Competitive scenario
9.1.5.4 UAE
9.1.5.4.1 UAE antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.5.4.2 Key country dynamics
9.1.5.4.3 Disease prevalence
9.1.5.4.4 Regulatory framework
9.1.5.4.5 Competitive scenario
9.1.5.5 Kuwait
9.1.5.5.1 Kuwait antibiotic resistance market estimates and forecast, 2018 – 2030 (USD Million)
9.1.5.5.2 Key country dynamics
9.1.5.5.3 Disease prevalence
9.1.5.5.4 Regulatory framework
9.1.5.5.5 Competitive scenario
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New product launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.3 Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 ACHAOGEN, INC.
10.4.1.1 Company overview
10.4.1.2 Financial performance
10.4.1.3 Product benchmarking
10.4.1.4 Strategic initiatives
10.4.2 Basilea Pharmaceutica Ltd.
10.4.2.1 Company overview
10.4.2.2 Financial performance
10.4.2.3 Product benchmarking
10.4.2.4 Strategic initiatives
10.4.3 MELINTA THERAPEUTICS
10.4.3.1 Company overview
10.4.3.2 Financial performance
10.4.3.3 Product benchmarking
10.4.3.4 Strategic initiatives
10.4.4 Tetraphase Pharmaceuticals, Inc.
10.4.4.1 Company overview
10.4.4.2 Financial performance
10.4.4.3 Product benchmarking
10.4.4.4 Strategic initiatives
10.4.5 Theravance Biopharma
10.4.5.1 Company overview
10.4.5.2 Financial performance
10.4.5.3 Product benchmarking
10.4.5.4 Strategic initiatives
10.4.6 WOCKHARDT
10.4.6.1 Company overview
10.4.6.2 Financial performance
10.4.6.3 Product benchmarking
10.4.6.4 Strategic initiatives
10.4.7 Entasis therapeutics
10.4.7.1 Company overview
10.4.7.2 Financial performance
10.4.7.3 Product benchmarking
10.4.7.4 Strategic initiatives
10.4.8 Paratek Pharmaceuticals, Inc.
10.4.8.1 Company overview
10.4.8.2 Financial performance
10.4.8.3 Product benchmarking
10.4.8.4 Strategic initiatives
10.4.9 Seres Therapeutics
10.4.9.1 Company overview
10.4.9.2 Financial performance
10.4.9.3 Product benchmarking
10.4.9.4 Strategic initiatives
10.4.10 AbbVie
10.4.10.1 Company overview
10.4.10.2 Financial performance
10.4.10.3 Product benchmarking
10.4.10.4 Strategic initiatives
10.4.11 Merck & Co. Inc.
10.4.11.1 Company overview
10.4.11.2 Financial performance
10.4.11.3 Product benchmarking
10.4.11.4 Strategic initiatives
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Global antibiotic resistance market, by region, 2018 - 2030 (USD Million)
Table 4 Global antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 5 Global antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 6 Global antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 7 Global antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 8 Global antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 North America antibiotic resistance market, by country, 2018 - 2030 (USD Million)
Table 10 North America antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 11 North America antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 12 North America antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 13 North America antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 14 North America antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 U.S. antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 16 U.S. antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 17 U.S. antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 18 U.S. antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 19 U.S. antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Canada antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 21 Canada antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 22 Canada antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 23 Canada antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 24 Canada antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Europe antibiotic resistance market, by country, 2018 - 2030 (USD Million)
Table 26 Europe antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 27 Europe antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 28 Europe antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 29 Europe antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 30 Europe antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Germany antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 32 Germany antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 33 Germany antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 34 Germany antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 35 Germany antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 UK antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 37 UK antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 38 UK antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 39 UK antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 40 UK antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 France antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 42 France antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 43 France antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 44 France antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 45 France antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Italy antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 47 Italy antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 48 Italy antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 49 Italy antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 50 Italy antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 51 Spain antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 52 Spain antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 53 Spain antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 54 Spain antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 55 Spain antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 56 Denmark antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 57 Denmark antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 58 Denmark antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 59 Denmark antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 60 Denmark antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Sweden antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 62 Sweden antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 63 Sweden antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 64 Sweden antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 65 Sweden antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 66 Norway antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 67 Norway antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 68 Norway antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 69 Norway antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 70 Norway antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 Asia Pacific antibiotic resistance market, by country, 2018 - 2030 (USD Million)
Table 72 Asia Pacific antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 73 Asia Pacific antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 74 Asia Pacific antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 75 Asia Pacific antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 76 Asia Pacific antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 77 China antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 78 China antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 79 China antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 80 China antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 81 China antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 82 Japan antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 83 Japan antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 84 Japan antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 85 Japan antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 86 Japan antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 India antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 88 India antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 89 India antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 90 India antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 91 India antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 92 South Korea antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 93 South Korea antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 94 South Korea antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 95 South Korea antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 96 South Korea antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 97 Australia antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 98 Australia antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 99 Australia antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 100 Australia antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 101 Australia antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 102 Thailand antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 103 Thailand antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 104 Thailand antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 105 Thailand antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 106 Thailand antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 107 Latin America antibiotic resistance market, by country, 2018 - 2030 (USD Million)
Table 108 Latin America antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 109 Latin America antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 110 Latin America antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 111 Latin America antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 112 Latin America antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 113 Brazil antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 114 Brazil antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 115 Brazil antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 116 Brazil antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 117 Brazil antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 118 Mexico antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 119 Mexico antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 120 Mexico antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 121 Mexico antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 122 Mexico antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 123 Argentina antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 124 Argentina antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 125 Argentina antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 126 Argentina antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 127 Argentina antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 133 South Africa antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 134 South Africa antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 135 South Africa antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 136 South Africa antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 137 South Africa antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 143 UAE antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 144 UAE antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 145 UAE antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 146 UAE antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 147 UAE antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 148 Kuwait antibiotic resistance market, by disease, 2018 - 2030 (USD Million)
Table 149 Kuwait antibiotic resistance market, by pathogen, 2018 - 2030 (USD Million)
Table 150 Kuwait antibiotic resistance market, by drug class, 2018 - 2030 (USD Million)
Table 151 Kuwait antibiotic resistance market, by mechanism of action, 2018 - 2030 (USD Million)
Table 152 Kuwait antibiotic resistance market, by distribution channel, 2018 - 2030 (USD Million)
Table 153 Company Overview
Table 154 Financial Performance
Table 155 Product Benchmarking
Table 156 Strategic Initiatives
